Image For Activity Cover
GREQH2EM2406 - CMLE/CME - Pan-Tumor Her2 Testing: Practical Considerations for the Laboratory
Course Description

Pan-Tumor Her2 Testing: Practical Considerations for the Laboratory 

Activity Description: 

This enduring recording from the 2024 ASCP annual meeting is designed to review recent data, clinical cases, and practical considerations when performing and interpreting HER2 testing across different types of tumors. Faculty will also provide practical tips to prepare pathologists and laboratory professionals for a new era of pan-tumor HER2 testing. Based on recent clinical data and new treatment options for patients, laboratories need to be equipped to perform HER2 testing across multiple types of unresectable or metastatic solid tumors.  

Provided by the American Society for Clinical Pathology in partnership with Q Synthesis LLC.  

Course topics include: 

  • Review of recent clinical data and new treatment options related to HER2 testing 

  • HER2 testing in patients with advanced solid tumors 

  • HER2-directed therapy and clinical outcomes  

Target Audience 
This activity has been designed to meet the educational needs of pathologists and laboratory professionals.  

 

Faculty/Authors

Joseph Kim, MD, MPH, MBA
President, Q Synthesis LLC 

Jefree Schulte, MD
Assistant Professor, Department of Pathology and Laboratory Medicine
University of Wisconsin, Madison, WI 

Wei Zhang, MD, Ph.D.
Associate Professor, Pathology and Laboratory Medicine
University of Kansas, Kansas City, KS 

Physician's Competency: Patient Care, Medical Knowledge, Practice-Based Learning and Improvement 

CME/CMLE Credit: 1.0
Estimated Completion Time: 1.0 hour
Format: Online educational activity

Credit Designation Statement

The ASCP designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.  

ASCP designates this activity for a maximum of 1.0 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel.  

For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT. 

Method of Participation
To complete the activity and receive credit, the participant must participate in the course. CME certificates will be provided on-line.  

Commercial Support 
This activity is supported by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.    


Instructions

To claim CME/CMLE credit for the exercise, do the following:

  1. Review the Technical Considerations.
  2. Click Go to Content and click the first module of the course.
  3. Complete the Demographic Survey.
  4. Complete the Pre-Test.
  5. Review the Educational Activity.
  6. Complete and submit the Post Exam. You will have a maximum of three attempts to obtain the required score. You will be notified if you have met the credit requirements after each attempt.
  7. Submit the course Evaluation.
  8. Enter the maximum number of credits offered and click Claim CME/CMLE to register credit.

Faculty Disclosures 

Technical Considerations 

Release Dates: 12/9/2024     
Review Date:
Expiration Date: 12/9/2027       




Course Objectives

Upon completion of this activity, you will be able to:

  • Identify when HER2 testing may be indicated in patients with advanced solid tumors   

  • Describe how the use of certain HER2-directed therapy may impact clinical outcomes in patients with different types of solid tumors    

  • Outline how HER2 testing may be performed in different types of solid tumors    

  • Design laboratory workflows to achieve efficient, accurate, and equitable pan-tumor HER2 testing   

Summary
Availability: On-Demand
Credit Offered:
1 CME/CMLE Credit
Powered By